Risk factors for acute graft-versus-host disease
- PMID: 3322360
- DOI: 10.1111/j.1365-2141.1987.tb06160.x
Risk factors for acute graft-versus-host disease
Abstract
Acute graft-versus-host disease (GvHD) is an important complication of bone marrow transplantation in humans. Risk factors are imprecisely defined and controversial. We analysed data from 2036 recipients of HLA-identical sibling transplants for leukaemia or aplastic anaemia to identify risk factors for GvHD. Analyses indicate that grading of GvHD can be reproducibly divided into absent or mild versus moderate to severe; 2-year actuarial probability was 54% (95% confidence interval 52-56%) for absent or mild and 46% (44-48%) for moderate to severe. Factors predictive of development of moderate to severe GvHD include donor/recipient sex-match (female----male greater than others, relative risk 2.0, P less than 0.001). This risk was markedly increased if female donors for male recipients were previously pregnant or transfused (relative risk 2.9, P less than 0.0001). Older patients were at increased risk of GvHD (relative risk 1.6, P less than 0.001), but the age gradient was modest, even the youngest patients had a substantial risk of GvHD and, if parous or transfused female----male transplants were excluded, age was not a significant risk factor. Cyclosporine or methotrexate were equally effective at preventing GvHD and were superior to no prophylaxis (relative risk 2.3, P less than 0.01). These data should be useful in estimating the risk of acute GvHD in an individual patient and in designing clinical trials to investigate methods to modify or prevent GvHD.
Similar articles
-
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.N Engl J Med. 1988 Jul 14;319(2):65-70. doi: 10.1056/NEJM198807143190201. N Engl J Med. 1988. PMID: 3288872
-
Marrow transplant experience for children with severe aplastic anemia.Am J Pediatr Hematol Oncol. 1994 Feb;16(1):43-9. Am J Pediatr Hematol Oncol. 1994. PMID: 8311172
-
Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation.Br J Haematol. 1990 Apr;74(4):492-6. doi: 10.1111/j.1365-2141.1990.tb06340.x. Br J Haematol. 1990. PMID: 2346728
-
Acute graft-versus-host disease after allogeneic bone marrow transplantation.Can Med Assoc J. 1983 Nov 1;129(9):969-74. Can Med Assoc J. 1983. PMID: 6367917 Free PMC article. Review.
-
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.Clin Pharm. 1993 Oct;12(10):736-61. Clin Pharm. 1993. PMID: 8258255 Review.
Cited by
-
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.PLoS One. 2020 Sep 11;15(9):e0238824. doi: 10.1371/journal.pone.0238824. eCollection 2020. PLoS One. 2020. PMID: 32915853 Free PMC article.
-
Estimation in a semi-Markov transformation model.Int J Biostat. 2012 Jun 22;8(1):Article 15. doi: 10.1515/1557-4679.1233. Int J Biostat. 2012. PMID: 22740583 Free PMC article.
-
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.Blood. 2012 Jan 5;119(1):296-307. doi: 10.1182/blood-2011-06-364265. Epub 2011 Oct 18. Blood. 2012. PMID: 22010102 Free PMC article.
-
Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):14-23. doi: 10.1007/BF01969527. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2105890
-
Who is fit for allogeneic transplantation?Blood. 2010 Dec 2;116(23):4762-70. doi: 10.1182/blood-2010-07-259358. Epub 2010 Aug 11. Blood. 2010. PMID: 20702782 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials